OverviewChartNewsTraderScreen

MALIN CORP PLC/  IE00BVGC3741  /

Euronext Dublin
14/06/2024  00:00:00 Chg. +0.200 Volume Bid- Ask- High Low
5.900EUR +3.51% 104
Turnover: -		 -Bid Size: - -Ask Size: - 5.900 5.700
Newsfile Corp 10/06 R Public Relations Firm Joins The Malin, Nashville's Premier Workspace Cohort
GlobeNewswire 22/05 OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treat...
GlobeNewswire 11/03 Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting a...
GlobeNewswire 16/11/2023 Raymond and its Solutions and Support Centers Continue Pledge to Giving Back, Supporting Local Commu...
GlobeNewswire 09/11/2023 Peyto Celebrates 25 Years With Q3 2023 Results
GlobeNewswire 06/11/2023 Hammerhead Energy Inc. Announces Record Financial and Operating Results for Third Quarter 2023 and a...
TeleTrader 21/05/2022 Russia says it destroyed western arms for Ukraine
GlobeNewswire 09/03/2022 Peyto Funds Flow Rebounds in 2021
GlobeNewswire 14/12/2021 Gurnick Academy Tablet Giveaway
GlobeNewswire 09/12/2021 Gurnick Academy of Medical Arts Receives Capps' School of the Year Award
GlobeNewswire 23/11/2021 Law Firm Launches Missions-Oriented Web Series
GlobeNewswire 09/11/2021 Peyto Reports Third Quarter 2021 Results, Reinstates Monthly Dividend
GlobeNewswire 01/10/2021 McKinsey Receives Best-in-Class Distinctions in the POI 2021 Enterprise Planning Vendor Panorama Rep...
GlobeNewswire 23/09/2021 Gurnick Academy to Launch Nuclear Medicine Program
GlobeNewswire 02/09/2021 ESE Acquisition Target, Digital Motorsports, Announces Multi-Year Deal with Rising F3 Star Jack Dooh...
Newsfile Corp 12/08/2021 Fossil Fuels Far From Extinct: Oil and Gas Companies See Record Revenues
GlobeNewswire 11/08/2021 Peyto Reports Second Quarter 2021 Results
GlobeNewswire 12/05/2021 Peyto Posts Strong Q1 2021 Profits
GlobeNewswire 04/05/2021 Jounce Therapeutics Reports First Quarter 2021 Financial Results
GlobeNewswire 28/04/2021 Jounce Therapeutics to Present Trial in Progress Posters on the Phase 1 INNATE and the Phase 2 SELEC...
GlobeNewswire 27/04/2021 Jounce Therapeutics to Announce First Quarter 2021 Financial Results and Host Conference Call on Tue...
GlobeNewswire 13/04/2021 Nouveau Monde Confirms Its Firm Commitment to Achieving Past, Present & Future Carbon Neutrality, by...
GlobeNewswire 12/04/2021 Jounce Therapeutics Appoints Dmitri Wiederschain, Ph.D., as Chief Scientific Officer
GlobeNewswire 10/04/2021 Jounce Therapeutics Presents Preclinical Data from JTX-8064/LILRB2 Program at the 2021 American Asso...
GlobeNewswire 12/03/2021 Jounce Therapeutics Announces Closing of Public Offering and Full Exercise of Over-Allotment Option